FATE
Fate Therapeutics Inc
2.50$
+3.3%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.10 | 0.14 | 0.10 | 0.08 | 0.16 | 0.38 | 0.59 | 0.99 | 0.65 | 0.12 | 0.06 | |
| 0.80 | 0.78 | 0.83 | 0.82 | 1.00 | 1.29 | 1.52 | 0.06 | 0.14 | 1.60 | 1.04 | 0.11 | |
| -0.80 | -0.68 | -0.69 | -0.72 | -0.91 | 0.16 | -1.14 | 0.53 | 0.99 | -0.95 | -0.92 | -0.05 | |
| 0.80 | 0.78 | 0.83 | 0.82 | 1.00 | 1.29 | 1.52 | 2.27 | 3.31 | 1.75 | 1.19 | 0.91 | |
| 0.41 | 0.41 | 0.31 | 0.28 | 0.28 | 0.35 | 0.41 | 0.60 | 0.87 | 0.83 | 0.65 | 0.39 | |
| 1.22 | 1.19 | 1.15 | 1.10 | 1.28 | 1.63 | 0.41 | 2.82 | 4.18 | 0.98 | 0.93 | 1.19 | |
| -1.22 | -1.09 | -1.01 | -1.00 | -1.19 | -1.48 | -1.55 | -2.29 | -3.18 | -1.94 | -1.85 | -1.24 | |
| 0.03 | 0.09 | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 | 0.05 | 0.06 | – | – | – | |
| -1.27 | -1.18 | -1.05 | -1.02 | -1.19 | -1.44 | -2.10 | -2.24 | -2.91 | -1.64 | -1.64 | -1.15 | |
| 0.00 | -0.03 | -0.02 | 0.01 | 0.04 | -0.01 | -0.04 | -0.06 | -0.28 | 0.18 | – | – | |
| -1.27 | -1.18 | -1.05 | -1.02 | -1.19 | -1.44 | -2.10 | -2.24 | -2.63 | -1.64 | -1.64 | -1.15 | |
| -1.19 | -1.06 | -0.97 | -0.97 | -1.13 | -1.38 | -1.52 | -2.18 | -3.04 | -1.45 | -1.55 | -1.07 |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.